Skip to content
OpenCapital
Get started

Ultralife ULBI Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By segment

See full
Battery Energy Products29%+20.8%

Other financials

Income statement

See full
Revenue$47.4M-6.5%
Gross profit$11.5M+8.8%
Operating income-$1.5M-159%
Net income-$471.0K+68.1%
EPS (diluted)-$8.75-192%

Balance sheet

See full
Cash & equivalents$8.9M+2.0%
Total debt$50.7M-11.8%
Total equity$129.6M-5.0%
Total assets$220.6M-1.4%

Cash flow

See full
Operating cash flow$2.3M-33.0%
CapEx$770.0K-14.0%
Free cash flow$1.5M-39.9%

Valuation

See full
Market cap$105.27M-25.0%
Enterprise value$147.11M-19.9%
P/S0.6×-0.2×

Profitability

See full
Gross margin24.1%-1.7pp
Operating margin-3.1%-9.1pp
Net margin-2.6%-4.5pp
FCF margin7.8%+3.9pp

Returns & leverage

See full
Return on equity-3.7%-6.1pp
Debt / equity0.4×0.0×
Current ratio2.6×-0.7×